EMPLICITI vs SARCLISA ESCENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. EMPLICITI and SARCLISA ESCENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EMPLICITI	SARCLISA ESCENA
Rating	72/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ELOTUZUMAB	ISATUXIMAB-IRFC
Manufacturer	Bristol Myers Squibb	Sanofi-Aventis U.S. LLC
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Multiple Myeloma	Multiple Myeloma

empliciti sarclisa escena

Rating

72/100

70/100

Pharmacy pays

—

Type

Active ingredient

ELOTUZUMAB

ISATUXIMAB-IRFC

Manufacturer

Bristol Myers Squibb

Sanofi-Aventis U.S. LLC

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Multiple Myeloma

Frequently asked questions

Which is better-rated, Empliciti or Sarclisa Escena?

By our independent rating, Empliciti scores higher — 3.6 vs 3.5 out of 5 for Sarclisa Escena. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Empliciti and Sarclisa Escena?

Empliciti contains Elotuzumab, while Sarclisa Escena contains Isatuximab-Irfc — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.